As of the June 30, 2026, we had future minimum operating lease payments under non-cancelable leases of $11.6 million related to leases we have recognized on our condensed consolidated balance sheet, which included existing laboratory and office leases and the new corporate headquarters lease that commenced June 1, 2025 in Boston, Massachusetts.

filing / Aug 5, 2026 / receipt

The implementation of cost containment measures or other healthcare reforms may prevent us from being able to generate revenue, attain profitability, or commercialize our products.

filing / Aug 5, 2026 / receipt

These increased costs will continue to decrease our net income or increase our net loss, and may require us to reduce costs in other areas of our business or increase the prices of our products or services.

filing / Aug 5, 2026 / receipt

These increases will likely include additional costs related to the hiring of additional personnel and fees paid to outside consultants, among other expenses.

filing / Aug 5, 2026 / receipt

• a $4.0 million increase in personnel-related costs due to an increase in headcount, which consisted primarily of salaries, bonuses, and other compensation-related costs of $2.7 million and stock-based compensation of $1.3 million;

filing / Aug 5, 2026 / receipt

In February 2024, the Company entered into a lease in San Diego, California to lease a total of 20,626 square feet for laboratory and office space.

filing / Aug 5, 2026 / receipt

As of the March 31, 2026, we had future minimum operating lease payments under non-cancelable leases of $12.5 million related to leases we have recognized on our condensed consolidated balance sheet, which included existing laboratory and office leases and the new corporate headquarters lease that commenced June 1, 2025 in Boston, Massachusetts.

filing / May 7, 2026 / receipt

The implementation of cost containment measures or other healthcare reforms may prevent us from being able to generate revenue, attain profitability, or commercialize our products.

filing / May 7, 2026 / receipt

These increased costs will continue to decrease our net income or increase our net loss, and may require us to reduce costs in other areas of our business or increase the prices of our products or services.

filing / May 7, 2026 / receipt

These increases will likely include additional costs related to the hiring of additional personnel and fees paid to outside consultants, among other expenses.

filing / May 7, 2026 / receipt

• a $3.9 million increase in personnel-related costs due to an increase in headcount, which consisted primarily of salaries, bonuses, and other compensation-related costs of $2.4 million, and stock-based compensation of $1.5 million;

filing / May 7, 2026 / receipt

In February 2024, the Company entered into a lease in San Diego, California to lease a total of 20,626 square feet for laboratory and office space.

filing / May 7, 2026 / receipt